Analisis Cost of Illness pada Pasien Diabetes Mellitus Dengan Terapi Glimepiride-Metformin Rawat Jalan Peserta BPJS di Puskesmas Ketapang II Kota Sampit

Abstract

Diabetes mellitus is a chronic disease that affects the costs incurred by patients during illness. The financingissuedfor the treatment of diabetes mellitus diseases can be measured using Cost of Illness analysis. Research objectivestofind out the total cost of treatment of diabetes mellitus patients BPJS participants with Glymepiride-Metformintherapy for one year. The method this study used a non-probability sampling technique with an accidental sampling method. This research conducted at Ketapang II Health Center with sample total 45 people. The instrument usedastructured interview which was previously tested for validity. Data were analyzed using Microsoft Excel. Result andconclusion, the estimate total cost of treatment of diabetes mellitus with outpatient glimepiride-metformin therapyofIndonesia Health Insurance participants at Ketapang II Health Center in Sampit city for one year is Rp.623.760-Rp.4.475.520. The direct medical cost per patient is Rp.143.760 - Rp.2.787.120. Non-medical direct cost is Rp.0-Rp.188.400. Indirect cost is Rp.480.000 - Rp.1.500.000. High cost are more expensive but the frequencyof visitsand patient compliance are orderly so that the therapeutic effect achieved is good, while the lowcost is cheaper butthe frequency of patient visits and patient compliance are not orderly so that the therapeutic effect achievedislessgood and not maximal.